IFNA1 and infection: In vitro studies have shown that SARS-CoV-2 replicates more efficiently at lower temperatures associated with the upper respiratory airway (33°C), which correlates with an overall weaker interferon (IFN)-mediated immune response to infection relative to lower respiratory airway (37°C) infection [16].